Action News 5: PEP Buddy helps people breathe easier
UC Venture Lab-backed startup aims to help people affected by COPD
A hands-free device developed by researchers at the University of Cincinnati could help the 12.5 million Americans who have chronic obstructive pulmonary disease breathe easier, Action News 5 in Memphis, Tennessee, reported.
PEP Buddy, a UC Venture Lab-backed startup, was created by Muhammad Ahsan Zafar, MD, and Ralph J. Panos, MD.
With COPD, it takes longer for people to get inhaled air out of their lungs. With each breath, extra air is retained in the lungs. This “air stacking” during activities (dynamic hyperinflation) is the primary reason for breathlessness in people with COPD and also leads to decreased oxygen levels.
PEP Buddy gives a gentle back pressure while the user breathes out, which assists in keeping open air tubes in the lungs and preventing them from collapsing. The device also prolongs the exhalation phase and reduces the breathing rate, decreasing the effects of air stacking.
“It’s just simply placed in the mouth, one breath in through the nose, and then out through the device. That resistance to airflow creates the back pressure, which relieves the air trapping and dynamic hyperinflation,” Panos said.
Featured image at top: PEP Buddy device. Photo/PEP Buddy
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Struggling with daily HIV meds?
March 23, 2026
For many people living with HIV, staying healthy depends on something deceptively simple: taking a pill every day. But for those navigating unstable housing, stigma, mental health challenges or addiction, that daily routine can be hard to maintain. As Yahoo!Health recently reported, a new study suggests there may be a better option.
Extended-release buprenorphine viable, safe during pregnancy
March 23, 2026
MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.
Why are we so unhappy?
March 23, 2026
Suzie White, assistant professor in the School of Education, at the University of Cincinnati, spoke with Newsweek about the results of the 2026 World Happiness Report that placed the United States 23rd among countries.